User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 19:38, 19 August 2019
, 19 August 2019→The endocannabinoid system: + 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome', a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.
imported>Jukeboksi m (mv content unchanged) |
imported>Jukeboksi (→The endocannabinoid system: + 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome', a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.) |
||
| Line 41: | Line 41: | ||
* [https://www.intechopen.com/books/cannabinoids-in-health-and-disease/dietary-omega-6-omega-3-and-endocannabinoids-implications-for-brain-health-and-diseases 'Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases'], a 2016 peer-reviewed chapter. | * [https://www.intechopen.com/books/cannabinoids-in-health-and-disease/dietary-omega-6-omega-3-and-endocannabinoids-implications-for-brain-health-and-diseases 'Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases'], a 2016 peer-reviewed chapter. | ||
* [https://www.researchgate.net/publication/42369817_Endocannabinoids_and_pregnancy 'Endocannabinoids and pregnancy'], a 2010 literature review | * [https://www.researchgate.net/publication/42369817_Endocannabinoids_and_pregnancy 'Endocannabinoids and pregnancy'], a 2010 literature review | ||
* [https://www.sciencedaily.com/releases/2019/02/190206115550.htm 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome'], a 2019 animal model study found downregulating CB1 receptors beneficial for the mice. | |||
=== The endocannabinoid receptors === | === The endocannabinoid receptors === | ||